Sigilon Therapeutics’ stock soars 550% after Eli Lilly agrees to acquire company By: MarketWatch June 29, 2023 at 10:06 AM EDT Deal is focused on new cell therapies to improve diabetes care. Read More >> Related Stocks: Astrazeneca Plc ADR Eli Lilly Novo Nordisk A/S ADR Sernova Corp Sigilon Therapeutics Inc